Thursday, August 28, 2014 6:31:25 AM
On the negative side, the pps remains below the 50 day MA.
For those who keep wondering about my opinion on the company, I am sure that it has horrible management, however it has one excellent product in MANF, which if it does not actually make it to the clinic will most certainly attract investment dollars. IF they complete the p 16 deal, then they will have two interesting compounds. NOW, if I were Dr A, I would make a deal with Pharma and not a small biotech with no money like AMBS, so we will have to see about that. However, if they do not finalize P16 they have MANF.
Within that framework, the PPS will go up and down, and so, when I am materially incorrect about my predictions about the compounds or the pps then let me know, but so far, I've hit every one of the marks. And that is what it is all about.
The truth is incontrovertible. Malice may attack it, ignorance may deride it, but in the end, there it is.
Winston Churchill
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM